Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products
April 12, 2021
Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.
Gene Therapy for Rare Disorders 2021
January 22, 2021
Meet Veristat at the Virtual event taking place 23-24 February 2021
Webinar | Roadmap to Market for Cell and Gene Therapies
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
Webinar | Reducing Study Build Time from Weeks to Days
October 1, 2020
View Webinar On-Demand
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Cell and Gene Meeting On The Mesa
August 3, 2020
Meet Veristat at the Virtual event taking place October 12-14, 2020.
Gene Therapy for Rare Disorders Europe
August 3, 2020
Meet Veristat at the Virtual event taking place 26-28 October 2020.
Webinar | Minimize Disruption of Your Oncology Trial
June 4, 2020
View the On-Demand Webinar
View the On-Webinar
DIA 2020 Virtual Meeting ⎪Booth 138
February 19, 2020